Overview

Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine

Status:
Unknown status
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
the aim of this study is to study the pharmacokinetics and dynamics of nebulized dexmetedomidine in children undergoing major abdominal cancer surgery.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine